Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07614906

Nitric Oxide Consumption as a Predictor of Vasospasm in Subarachnoid Hemorrhage

Sponsor: Massachusetts General Hospital

View on ClinicalTrials.gov

Summary

The goal of this observational study is to understand if angiographic cerebral vasospasm (CV) can be predicted by levels of nitric oxide (NO) consumption in patients with aneurysmal subarachnoid hemorrhage (SAH). To reach this goal, the investigators will compare NO consumption levels in SAH and non-SAH patients. NO consumption levels will be analyzed from samples of participants' cerebral spinal fluid (CSF).

Official title: Nitric Oxide Consumption as a Predictor of Vasospasm in Subarachnoid Hemorrhage (SAH): a Prospective Observational Study

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

40

Start Date

2024-03-03

Completion Date

2027-06

Last Updated

2026-05-29

Healthy Volunteers

Yes

Locations (2)

Massachusetts General Hospital

Boston, Massachusetts, United States

Fondazione Policlinico Universitario Agostino Gemelli

Rome, Italy